Epilepsy in autism

Roberto Tuchman, Isabelle Rapin

Research output: Contribution to journalArticle

457 Citations (Scopus)

Abstract

There is an increased but variable risk of epilepsy in autism. Three main factors - age, cognitive level, and type of language disorder - account for variability in the reported prevalence of epilepsy. The prevalence is highest in studies that have included adolescents and young adults, individuals with moderate to severe mental retardation and those with motor deficits, and individuals with severe receptive language deficits. The association of autism with clinical or subclinical epilepsy might denote common genetic factors in some cases. Whether subclinical epilepsy has adverse effects on cognition, language, and behaviour is debated, as is the relation of autistic regression with an epileptiform electroencephalogram to Landau-Kleffner syndrome. There is no evidence-based treatment recommendation for individuals with autism, regression, and subclinical epilepsy. Double-blind studies with sufficient power to resolve this issue are urgently needed.

Original languageEnglish
Pages (from-to)352-358
Number of pages7
JournalLancet Neurology
Volume1
Issue number6
DOIs
StatePublished - Jun 1 2002

Fingerprint

Autistic Disorder
Epilepsy
Landau-Kleffner Syndrome
Language
Language Disorders
Age Factors
Double-Blind Method
Intellectual Disability
Cognition
Young Adult
Electroencephalography
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Epilepsy in autism. / Tuchman, Roberto; Rapin, Isabelle.

In: Lancet Neurology, Vol. 1, No. 6, 01.06.2002, p. 352-358.

Research output: Contribution to journalArticle

Tuchman, R & Rapin, I 2002, 'Epilepsy in autism', Lancet Neurology, vol. 1, no. 6, pp. 352-358. https://doi.org/10.1016/S1474-4422(02)00160-6
Tuchman, Roberto ; Rapin, Isabelle. / Epilepsy in autism. In: Lancet Neurology. 2002 ; Vol. 1, No. 6. pp. 352-358.
@article{5c1114b28e0c4c9890224d24fa730a84,
title = "Epilepsy in autism",
abstract = "There is an increased but variable risk of epilepsy in autism. Three main factors - age, cognitive level, and type of language disorder - account for variability in the reported prevalence of epilepsy. The prevalence is highest in studies that have included adolescents and young adults, individuals with moderate to severe mental retardation and those with motor deficits, and individuals with severe receptive language deficits. The association of autism with clinical or subclinical epilepsy might denote common genetic factors in some cases. Whether subclinical epilepsy has adverse effects on cognition, language, and behaviour is debated, as is the relation of autistic regression with an epileptiform electroencephalogram to Landau-Kleffner syndrome. There is no evidence-based treatment recommendation for individuals with autism, regression, and subclinical epilepsy. Double-blind studies with sufficient power to resolve this issue are urgently needed.",
author = "Roberto Tuchman and Isabelle Rapin",
year = "2002",
month = "6",
day = "1",
doi = "10.1016/S1474-4422(02)00160-6",
language = "English",
volume = "1",
pages = "352--358",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "6",

}

TY - JOUR

T1 - Epilepsy in autism

AU - Tuchman, Roberto

AU - Rapin, Isabelle

PY - 2002/6/1

Y1 - 2002/6/1

N2 - There is an increased but variable risk of epilepsy in autism. Three main factors - age, cognitive level, and type of language disorder - account for variability in the reported prevalence of epilepsy. The prevalence is highest in studies that have included adolescents and young adults, individuals with moderate to severe mental retardation and those with motor deficits, and individuals with severe receptive language deficits. The association of autism with clinical or subclinical epilepsy might denote common genetic factors in some cases. Whether subclinical epilepsy has adverse effects on cognition, language, and behaviour is debated, as is the relation of autistic regression with an epileptiform electroencephalogram to Landau-Kleffner syndrome. There is no evidence-based treatment recommendation for individuals with autism, regression, and subclinical epilepsy. Double-blind studies with sufficient power to resolve this issue are urgently needed.

AB - There is an increased but variable risk of epilepsy in autism. Three main factors - age, cognitive level, and type of language disorder - account for variability in the reported prevalence of epilepsy. The prevalence is highest in studies that have included adolescents and young adults, individuals with moderate to severe mental retardation and those with motor deficits, and individuals with severe receptive language deficits. The association of autism with clinical or subclinical epilepsy might denote common genetic factors in some cases. Whether subclinical epilepsy has adverse effects on cognition, language, and behaviour is debated, as is the relation of autistic regression with an epileptiform electroencephalogram to Landau-Kleffner syndrome. There is no evidence-based treatment recommendation for individuals with autism, regression, and subclinical epilepsy. Double-blind studies with sufficient power to resolve this issue are urgently needed.

UR - http://www.scopus.com/inward/record.url?scp=0041510584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041510584&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(02)00160-6

DO - 10.1016/S1474-4422(02)00160-6

M3 - Article

VL - 1

SP - 352

EP - 358

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 6

ER -